EBS earnings
Emergent BioSolutions (EBS) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
EBS earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 0.60 | -0.09 | 805.88% | $234.30M |
| Q1 2026 | Apr 30, 2026 | 0.21 | -0.25 | 184.00% | $156.10M |
| Q4 2025 | Feb 26, 2026 | -0.43 | 0.11 | -490.91% | $148.70M |
| Q3 2025 | Oct 29, 2025 | 1.06 | -0.12 | 983.33% | $231.10M |
| Q2 2025 | Aug 6, 2025 | 0.16 | -0.26 | 161.54% | $140.90M |
| Q1 2025 | May 7, 2025 | 0.71 | 0.49 | 44.90% | $222.20M |
| Q4 2024 | Mar 3, 2025 | 0.05 | -0.35 | 114.29% | $194.70M |
| Q3 2024 | Nov 6, 2024 | 1.37 | 0.49 | 179.59% | $293.80M |
| Q2 2024 | Aug 6, 2024 | -2.32 | -0.97 | -139.18% | $254.70M |
| Q1 2024 | May 1, 2024 | 0.59 | -0.86 | 168.60% | $300.40M |
| Q4 2023 | Mar 6, 2024 | -0.77 | -0.33 | -133.33% | $276.60M |
| Nov 7, 2023 | -1.44 | -0.22 | -554.55% | – | |
| Aug 8, 2023 | -1.06 | -0.49 | -116.33% | – | |
| May 9, 2023 | -3.17 | -1.67 | -89.82% | – | |
| Feb 27, 2023 | -0.31 | 0.04 | -875.00% | – | |
| Nov 8, 2022 | -1.27 | -0.06 | -2016.67% | – | |
| Aug 1, 2022 | -0.86 | 0.63 | -236.51% | – | |
| Apr 28, 2022 | 0.18 | 0.13 | 38.46% | – | |
| Feb 24, 2022 | 4.50 | 4.27 | 5.39% | – | |
| Nov 4, 2021 | -0.36 | 2.35 | -115.32% | – |
- EBS beat EPS estimates in 46 of its last 78 reports.
Updated 2026-11-03 23:15 UTC